Comparison of Efficiency in Dose Planning of the Leksell Gamma Knife Perfexion and Model C : Clinical Study by 장종희 & 박용구
114 
Introduction
Since the Leksell Gamma Knife (ELEKTA Instruments AB, 
Stockholm, Sweden)(LGK) was first developed in 1967, newer 
versions of the machine have been developed as a series of the 
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ABSTRACT
Objective：The purpose of this study was to compare the dose planning between the Leksell Gamma Knife Perfexion (LGK 
PFX) and the Leksell Gamma Knife C (LGK C) using variable indices.
Methods：A total of 100 cases, which were composed of 35 meningiomas, 20 vestibular schwannomas, 35 metastases, and 
10 pituitary adenomas, were enrolled in this study. First, these cases were treated with the LGK PFX and then, were re-
planned with the LGK C. We compared these two models in terms of the number of shots, the percentage of coverage, the 
conformity index (CI), Paddick’s conformity index (PCI), the gradient index (GI), and the beam on time.
Results：The LGK PFX completely outperformed the LGK C in terms of GI and the LGK PFX tended to have a longer 
beam on time than that of the LGK C. However, in patients with schwannomas, the LGK PFX outperformed the LGK C in 
terms of the CI, PCI, and GI, and in patients with pituitary adenomas, the LGK PFX outperformed the LGK C in terms of 
the percentage of coverage, PCI, and GI with statistical significance.
Conclusion：The LGK PFX is an entirely redesigned radiosurgery unit accompanied by the development of software. The 
LGK PFX is supposed to achieve highly conformal dose prescription consisting of many isocenters with a reasonable treat-
ment time.
KEY WORDS ： Radiosurgery·Gamma Knife·Dose planning·Perfexion·Model C.
LGK models including A, B, C, and 4-C. Recently, the Leksell 
Gamma Knife Perfexion (LGK PFX), an entirely redesigned 
unit, was introduced in 2006.
The LGK PFX has many different features from previous 
models of the LGK. First, as far as the radiation unit itself, the 
source geometry has been changed to an array of 192 Cobalt-60 
sources, arranged in a cone section configuration. Additionally, 
the collimators have been replaced by a single, larger, 12-cm-
thick tungsten collimator array, subdivided into eight sectors. 
The 4- and 8-mm collimators remain, but the 14- and 18-mm 
collimators have been replaced with 16-mm collimators, and 
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the beam diameters are automatically changed. In comparison 
with previous models, the LGK PFX shows a greater treatment 
range of more than three times, in the x and y dimensions of 
160 mm (x, 20-180 mm) and 180 mm (y, 10-190 mm).
Second, instead of adjusting the collimator helmet, the pa-
tient positioning system (PPS) moves the patient to the prese-
lected stereotactic coordinates. The PPS moves faster than the 
automatic positioning system (APS) at speeds of up to 10 mm/s.
Third, the dose planning software was updated as the Lek-
sell GammaPlan PFX (LGP PFX). Compared to previous ver-
sions of the LGP, the LGP PFX accommodates improved im-
age fusion, nearly instantly on the previous treatment plan for 
new planning images, simplified dose prescription for multiple 
matrices, and decreased doses to critical structures using sector 
blocking, hybrid shots (also known as composite shots), and a 
unique process called dynamic shaping.1)
With these evolutions of hardware and software, the LGK 
PFX has been known to have radiobiological benefits such as 
increased conformity, improved accuracy, decreased normal tis-
sue irradiation, and reduced treatment time. The purpose of this 
study was to compare dose planning between the LGK PFX 
and the LGK C using variable indices.
Materials and Methods
1. Patient population
From November, 2008 to March, 2009, a total of 250 cases 
were treated with the LGK PFX in our center. Among the cas-
es, 100 cases with a size larger than 4 mm3, were eligible for 
this study. Pathologically, cases were composed of 35 menin-
giomas, 20 vestibular schwannomas, 35 metastases, and 10 pi-
tuitary adenomas. First, these cases were treated using the LGK 
PFX with the LGP PFX version 8.3, and then were re-planned 
with LGK C with LGP 5.34. Adjustment of the dose rate was 
carried out between the two models.
2. Evaluation parameters
All paired plans (LGK PFX with the LGP PFX version 8.3 
and LGK C with the LGP 5.34) were compared for the mean 
values of the number of shots, percentage of coverage, the con-
formity indices (CI) as described by Shaw et al.6) and Paddick 
(PCI),3) the gradient index (GI) as described by Paddick and 
Lippitz,4) and the beam-on time. The conformity index (CI)6) 




where PIV was the volume covered in prescription isodose, and 
TV was the defined target volume. The Paddick conformity in-
dex (PCI)3) used the target volume covered in the prescription 





The gradient index as described by Paddick and Lippitz was 
the ratio of the volume of half the prescription isodose to the 




where PIV25% and PIV50% are the 25% and 50% isodose volume, 
respectively.
Results
For the entire patient group, there was a statistically signifi-
cant difference between the LGK PFX and the LGK C in terms 
of the number of shots (25.5 vs. 20.4), GI (2.640 vs. 2.786), and 
beam on time (68.7 vs. 59.9). There was no significant differ-
ence between the two models for the percentage of coverage, 
CI, and PCI.
However, there was a different trend in the subgroup analy-
sis. In vestibular schwannomas, the LGK PFX outperformed 
the LGK C in terms of the CI (1.052 vs. 1.105), PCI (0.916 vs. 
0.864), and GI (2.63 vs. 2.75), whereas there was no significant 
difference in the number of shots, the percentage of coverage, 
and the beam on time. In the pituitary adenomas subgroup, the 
LGK PFX outperformed the LGK C in terms of the percent-
age of coverage (97.3 vs. 95.1), PCI (0.825 vs. 0.782), and GI 
(2.67 vs. 2.86). In the meningiomas and metastases subgroups, 
there was similar trend with the total group, in which the LGK 
PFX outperformed the LGK C in terms of GI. The outcomes 
for the dose-planning parameters of the LGK PFX with the 
LGP PFX version 8.3 and the LGK C with the LGP 5.34 were 
summarized in Table 1.
Discussion
When the treatment modality has radiological benefits, it re-
fers to versatile planning, increased conformity, increased accu-
racy (or sensitivity), decreased irradiation of normal tissue, and 
decreased treatment time. In the present study, the LGK PFX 
outperformed the LGK C in terms of selectivity and showed a 
similar performance in terms of conformity. Additionally, in the 
LGK PFX, the number of shots was larger, and the beam on 
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time was longer than in the LGK C (Table 2).
In the LGK PFX, the 14-mm and 18-mm collimators were 
replaced with 16-mm collimators. In the previous study, the 
14-mm and 18-mm collimators were used for only 8.4% and 
1.4% of isocenters in dose planning with the LGK C.1) There-
fore, it was reasonable to replace the collimators, and it was 
possible to make highly conformal shots with more isocenters. 
The 4-mm collimator was used very selectively with the LGK 
C, while it was applied liberally for the LGK PFX.2) Similarly, 
dynamic shaping by sector blocking was used frequently in 
the LGK PFX. These factors resulted in an increased number 
of shots, and subsequently increased the beam on time.
Generally, the overall treatment time consists of the set-up 
time and beam on time. In the present study, measurement of 
set-up time was not possible ; however the overall treatment 
time was probably shorter in the LGK PFX than in the LGK 
C. The set-up time includes time that is used in the initial dock-
ing of the patient, position check, coordinate setting in the APS 
mode, collimator change, change from low to high docking, 
change from APS to trunnion mode, coordinating setting in the 
trunnion mode, initial/final couch move in the treatment posi-
tion, and coordinate and sector change (only in the LGK PFX).2) 
In the LGK PFX, PPS moves faster than APS in the LGK C 
up to a rate of 10 mm/s and there is no time penalty for chang-
ing a collimator helmet as in the LGK C. Automatic coordi-
nate and sector change take less than 1 second. Even though 
in the present study, the beam on time increased in the LGK 
PFX, which was because of an increased number of shots and 
blocking sectors, the overall treatment time was supposed to 
be shorter in the LGK PFX because of the treatment efficacy. 
Previous studies supported our assumption.1,2,5)
In the subgroup analysis, the LGK PFX outperformed the 
LGK C in terms of conformity and the percentage of coverage 
for vestibular schwannomas and pituitary adenomas. These 
kinds of tumor are generally surrounded by eloquent structures 
including optic nerves and other cranial nerves. The new ver-
sion of the LGP PFX can generate various shapes originating 
from a single isocenter using the composite shot feature. Once 
the critical structure is defined, a so called “risk volume”, the 
composite shot feature makes various beam shaping as the lev-
Table 1. Comparison of dose-planning using the LGK C with the LGP 5.34 and the LGK PFX with the LGP PFX version 8.3
No. of shots Coverage (%) CI PCI GI Beam on time (min)
Meningioma (n=35, TV : 5.6 mm3)
C *18.7* 99.7 1.113 0.892 2.80* *43.1*
PFX *26.5* 99.7 1.082 0.924 2.66* *61.7*
Schwannoma, VIII (n=20, TV : 5.2 mm3)
C 22.6 98.6 *1.105* *0.864* 2.75* 71.7
PFX 24.9 98.8 *1.052* *0.916* 2.63* 77.5
Metastasis (n=35, TV : 11.6 mm3)
C *19.4* 99.9 1.241 0.792 2.73* *45.3*
PFX *25.4* 99.9 1.198 0.801 2.60* *52.7*
Pituitary adenoma (n=10, TV : 4.7 mm3)
C 23.1 *95.1* 1.163 *0.782* 2.86* 79.3
PFX 23.5 *97.3* 1.152 *0.825* 2.67* 82.8
Total (n=100, TV : 7.3 mm3)
C *20.4* 99.1 1.155 0.834 02.786* *59.9*
PFX *25.5* 99.3 1.122 0.866 02.640* *68.7*
* : statistically significant, p-value ＜0.05. LGK C : Leksell Gamma Knife C, LGP : Leksell GammaPlan, LGK PFX : Leksell Gamma Knife Per-
fexion, LGP PFX : Leksell GammaPlan Perfexion, CI : conformity index, PCI : Paddick conformity index, GI : gradient index, TV : target 
volume 
Table 2. Performance summary of the LGK PFX compared to the LGK C
No. of shots Conformity Selectivity Beam on Time
Meningioma More Almost same Better Longer
Schwannoma Almost same Better Better Almost same
Metastasis More Almost same Better Longer
Pituitary adenoma Almost same Better Better Almost same
Total More Almost same Better Longer
LGK PFX : Leksell Gamma Knife Perfexion, LGK C : Leksell Gamma Knife C
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el of dose to the risk volume using dynamic shaping or sector 
blocking. In the recent study, the LGK PFX showed better per-
formance in terms of conformity and energy distribution than 
the LGK C with sparing cochlear function.7) Therefore in a case 
where the target is surrounded by important structures, the 
LGK PFX is a reasonable choice showing a better conformity 
and the percentage of coverage than that of the LGK C. Addi-
tionally, in terms of selectivity, which means how well the pre-
scribed dose is fitted not only to the target volume but also to 
normal tissues, the LGK PFX can achieve high selectivity (Ta-
ble 2).
Conclusion
The LGK PFX is an entirely redesigned radiosurgery unit 
accompanied by the development of new software, as the LGP 
PFX. New feature of this unit include an increased mechanical 
treatment range, automatic change and adjustment of collima-
tors, and replacement of 14- and 18-mm collimators to 16-mm 
collimator. In the present study, the LGK PFX showed a simi-
lar conformity to the LGK C with longer beam on time and an 
increased number of shots. However, for pituitary adenomas 
and vestibular schwannomas, the LGK PFX outperformed the 
LGK C in terms of conformity and selectivity. The LGK PFX 
was supposed to achieve highly conformal dose prescription 
consisting of many isocenters with a reasonable treatment time.
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